A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine
Status:
Completed
Trial end date:
1994-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to make didanosine (ddI) available to children with AIDS who are
clinically deteriorating on zidovudine (AZT) or intolerant to AZT and cannot enter the Phase
II ddI programs due to protocol exclusion or geographic location.